[1] GODFREY E W,NITKIN R M,WALLACE B G,et al.Components of torpedo electric organ and muscle that cause aggregation of acetylcholine receptors on cultured muscle cells[J].J Cell Biol,1984,99(2):615-627.
[2] TSEN G,HALFTER W,KROGER S,et al.Agrin is a heparan sulfate proteoglycan[J].J Biol Chem,1995,270(7):3392-3399.
[3] MCMAHAN U J,HORTON S E,WERLE M J,et al.Agrin isoforms and their role in synaptogenesis[J].Curr Opin Cell Biol,1992,4(5):869-874.
[4] CHAKRABORTY S,NJAH K,HONG W.Agrin mediates angiogenesis in the tumor microenvironment[J].Trends in cancer,2020,6(2):81-85.
[5] HYUNA S,JACQUES F,LS R,et al.Global cancer statistics 2020:globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[6] ZHANG Q J,WAN L,XU H F.High expression of agrin is associated with tumor progression and poor prognosis in hepatocellular carcinoma[J].Math Biosci Eng,2019,16(6):7375-7383.
[7] TÁTRAI P,DUDÁS J,BATMUNKH E,et al.Agrin,a novel basement membrane component in human and rat liver,accumulates in cirrhosis and hepatocellular carcinoma[J].Lab Invest,2006,86(11):1149-1160.
[8] SAYAN C,MANIKANDAN L,FSH L,et al.An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinoma[J].Nat commun,2015,6:6184.
[9] PÉTER T.Selective deposition of agrin in the microvasculature of hepatocellular carcinoma:aspects in pathogenesis and differential diagnosis[J].Magy Onkol,2008,52(4):379-383.
[10] KIM N,STIEGLERA L,CAMERONT O,et al.Lrp4 is a receptor for Agrin and forms a complex with muSK[J].Cell,2008,135(2):334-342.
[11] CHAKRABORTY S,LAKSHMANAN M,SWAH L,et al.An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinoma[J].Nat commun,2015,6:6184.
[12] YOON H,DEHART P J,MURPHY J M,et al.Understanding the roles of fak in cancer:inhibitors,genetic models,and new insights[J].J Histochem Cytochem,2015,63(2):114-128.
[13] CHENG N,LI Y,HANZ G.Argonaute2 promotes tumor metastasis by way of up-regulating focal adhesion kinase expression in hepatocellular carcinoma[J].Hepatology,2013,57(5):1906-1918.
[14] 陈瑛,王丹丹,朱虹,等.抗肿瘤新靶点黏着斑激酶FAK及其抑制剂研究进展[J].中国现代应用药学,2016(2):255-260.
[15] CHAKRABORTY S,HONG W.Linking extracellular matrix Agrin to the hippo pathway in liver cancer and beyond[J].Cancers,2018,10(2):45.
[16] CHAKRABORTY S,NJAH K,POBBATI A V,et al.Agrin as a Mechanotransduction signal regulating yap through the hippo pathway[J].Cell Rep,2017,18(10):2464-2479.
[17] LV X,FANG C,YIN R,et al.Agrin para-secreted by PDGF-activated human hepatic stellate cells promotes hepatocarcinogenesis in vitro and in vivo[J].Oncotarget,2017,8(62):105340-105355.
[18] EILEEN M,MELINA A,GINI A,et al.Global burden of colorectal cancer in 2020 and 2040:incidence and mortality estimates from globocan[J].Gut,2023,72(2):338-344.
[19] WANG Z Q,SUN X L,WANG Y L,et al.Agrin promotes the proliferation,invasion and migration of rectal cancer cells via the wnt signaling pathway to contribute to rectal cancer progression[J].J Recept Sig Transd,2021,41(4):363-370.
[20] LI X Z,LU Y,WEN P H,et al.Matrine restrains the development of colorectal cancer through regulating the AGRN/Wnt/β-catenin pathway[J].Environ Toxicol,2023,38(4):809-819.
[21] KLEIN-SCORY S,KUBLER S,DIEHL H,et al.Immunoscreening of the extracellular proteome of colorectal cancer cells[J].BMC Cancer,2010,10:70.
[22] FRANCESCO L,ANTONIODM N,MONICA R,et al.Emerging hallmarks of metabolic reprogramming in prostate cancer[J].Int J Mol Sci,2023,24(2):910.
[23] 刘涛,张璐,张凡.Beclin-1和bcl-2蛋白对前列腺癌的发生、进展的作用[J].现代医学,2018,46(2):157-161.
[24] CHAKRAVARTY D,SBONER A,NAIR S S,et al.The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer[J].Nat commun,2014,5:5383.
[25] LI X,WANG X T,SONG W L,et al.Oncogenic properties of NEAT1 in prostate cancer cells depend on theCDC5L-AGRN transcriptional regulation circuit[J].Cancer Res,2018,78(15):4138-4149.
[26] LÁSZLÓ B,PETER S,LÁSZLÓ P.Agrin binds BMP2,BMP4 and TGFbeta1[J].PLoS One,2010,5(5):e10758.
[27] BARCELLOS-HOFF M H,CUCINOTTA F A.New tricks for an old fox:impact of TGFβ on the DNA damage response and genomic stability[J].Sci Signal,2014,7(341):re5
[28] BORGOÑO C A,JULIE-ANN G,JULIANO A,et al.Defining the extended substrate specificity of kallikrein 1-related peptidases[J].Biol Chem,2007,388(11):1215-1225.
[29] FELICITY L,GL M,SRILAKSHMI S,et al.The kallikrein 14 gene is down-regulated by androgen receptor signalling and harbours genetic variation that is associated with prostate tumour aggressiveness[J].Biol Chem,2012,393(5):403-412.
[30] KRYZA T,BOCK N,LOVELL S,et al.The molecular function of kallikrein-related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer[J].Mol Oncol,2020,14(1):105-128.
[31] MYERS J S,VON LERSNER A K,SANG Q X.Proteomic upregulation of fatty acid synthase and fatty acid binding protein 5 and identification of cancer-and race-specific pathway associations in human prostate cancer tissues[J].J Cancer,2016,7(11):1452-1464.
[32] CUEVAS-GONZÁLEZJ C,CUEVAS-GONZÁLEZM V,ESPINOSA-CRISTOBALL F,et al.Tumor invasion front in oral squamous cell carcinoma[J].World J Clin Cases,2022,10(28):10387-10390.
[33] KAWAHARA R,GRANATOD C,CARNIELLIC M,et al.Agrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma[J].PLoS One,2014,9(12):e115004.
[34] RIVERA C,ZANDONADIF S,SÁNCHEZ-ROMERO C,et al.Agrin has a pathological role in the progression of oral cancer[J].Br J Cancer,2018,118(12):1628-1638.
[35] 唐燕,张喆.PDL1和Ki67在三阴性乳腺癌中的表达及其与临床病理资料的相关性分析[J].现代医学,2021,49(7):793-797.
[36] TAKUYA N,TOMOYA K,MASATO M,et al.DNA methylation and HPV-associated head and neck cancer[J].Microorganisms,2021,9(4):801.
[37] DAI X F,REN T J,ZHANG Y X,et al.Methylation multiplicity and its clinical values in cancer[J].Expert Rev Mol Med,2021,23:e2.
[38] TITUS A J,WAYG P,JOHNSONK C,et al.Deconvolution of DNA methylation identifies differentially methylated gene regions on 1p36 across breast cancer subtypes[J].Sci Rep,2017,7(1):11594.
[39] LEFEBVRE C,BACHELOT T,FILLERON T,et al.Mutational profile of metastatic breast cancers:a retrospective analysis[J].PLoS Med,2016,13(12):e1002201.
[40] BERETOV J,WASINGER V C,MILLAR E K A,et al.Proteomic analysis of urine to identify breast cancer biomarker candidates using a label-free LC-MS/MS approach[J].PLoS One,2015,10(11):e0141876.
[41] DUMA N,SANTANA-DAVILA R,MOLINA J R.Non-small cell lung cancer:epidemiology,screening,diagnosis,and treatment[J].Mayo Clin Proc,2019,94(8):1623-1640.
[42] BUNN A P,DIMOU A.Systemic therapy for elderly patients with advanced non-small-cell lung cancers[J].J Clin Oncol,2018,36(25):2571-2574.
[43] HERMANF W,FRANCK P,CATHERINE S F,et al.The immune contexture in human tumours:impact on clinical outcome[J].Nat Rev Cancer,2012,12(4):298-306.
[44] ONIZUKA S,TAWARA I,SHIMIZU J,et al.Tumor rejection by in vivo administration of anti-CD25(interleukin-2 receptor alpha) monoclonal antibody[J].Cancer Res,1999,59(13):3128-3133.
[45] KOJI K,YOSHIHIRO O,HISASHI W,et al.Phase a study of FOXP3+ CD4 Treg depletion by Infusion of a humanized anti-CCR4 antibody,kw-0761,in cancer patients[J].Clin Cancer Res,2015,21(19):4327-4336.
[46] WANG Y A,LI X L,MO Y Z,et al.Effects of tumor metabolic microenvironment on regulatory T cells[J].Mol cancer,2018,17(1):168.
[47] NGUYEN D P,LI J Y,TEWARI A K.Inflammation and prostate cancer:the role of interleukin 6(IL-6)[J].BJU Int,2014,113(6):986-992.
[48] MARIA S E,SAMMARTINO M V,AGUIAR P P R,et al.High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer[J].PLoS One,2017,12(7):e0181125.
[49] LIU C,LI Y,WEI M,et al.Identification of a novel glycolysis-related gene signature that can predict the survival of patients with lung adenocarcinoma[J].Cell Cycle,2019,18(5):568-579.
[50] HAN L,SHI H,MA S,et al.Agrin promotes non-small cell lung cancer progression and stimulates regulatory T cells via increasing IL-6 secretion through PI3K/AKT pathway[J].Front oncol,2021,11:804418.
[51] LI D,GU Q,XIE Z,et al.Clinical significance of nuclear localisation of agrin in lung adenocarcinoma[J].Pol J pathol,2019,70(3):198-204.
[52] 李荣,赵静.宫颈癌与HPV感染的关系及患者术后肿瘤分期升级的影响因素分析[J].现代医学,2022,50(7):884-888.
[53] RAJKUMAR T,SABITHA K,VIJAYALAKSHMI N,et al.Identification and validation of genes involved in cervical tumourigenesis[J].BMC Cancer,2011,11:80.
[54] 冯思佳,崔静,杨璐,等.集聚蛋白基因在不同宫颈癌细胞中的表达[J].新乡医学院学报,2016(5):365-368.
[55] RUIVO C F,BASTOS N,ADEM B,et al.Extracellular vesicles from pancreatic cancer stem cells Lead an intratumor communication network(EVNet) to fuel tumour progression[J].Gut,2022,71(10):2043-2068.
[56] HE M M,CHENG C,TU J X,et al.Agrin expression is correlated with tumor development and poor prognosis in cholangiocarcinoma[J].J Int Med Res,2021,49(5):3000605211009722. |
